Search results for " somatropin"
Article
Biosimilars: Making the Switch Comes with Challenges
By Sean Milmo
The use of biosimilars continues to increase strongly in Europe, 10 years after the first biosimilar, a somatropin, was approved by the European Union (EU). With approximately 20 new…
Article
Biopharma in 2015: A Year for Approvals and Innovations
As of 2015, the EU approved 19 biosimilars, out of 21 submissions, mostly for three reference biologics such as Somatropin, Epoetin alfa, and Filgrastim.3
In addition, nine of the therapeutic biolo…
Article
EMA Collaborates with HTA Assessment Networks
Within less than two years, biosimilar somatropin, the growth hormone, rose from a market share of around 20% in the country to over half.
In Germany, one of Europe’s biggest markets for biosimilar…